Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Eiger Bio Receives Orphan Designation for Lonafarnib, a First In Class, Investigational Treatment for Hepatitis Delta Virus (HDV) Infection 2014-12-22 21:00
Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib -- Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2014-12-22 21:00
Canopus BioPharma Inc. announces positive results from an In-Vitro live Ebola Virus study 2014-12-19 22:00
Aptuit Adds Hot Melt Extrusion Technology To Its Integrated API And Formulation Development Expertise 2014-12-18 03:27
Kinex Pharmaceuticals Appoints Chief Operating Officer 2014-12-17 23:42
LKK Health Products Group Promotes Industrial Ecosystem 2014-12-12 09:00
LKK Health Products Group Promotes Industrial Ecosystem 2014-12-12 09:00
Mundipharma Donates BETADINE Anti-viral Supplies to Direct Relief to Support the Fight Against Ebola in West Africa 2014-12-11 17:18
Zydus Launches World's First Biosimilar of Adalimumab 2014-12-09 19:01
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma at ASH Annual Meeting 2014-12-09 09:30
Takeda Presents Phase 2 Data on Maintenance with Single-Agent Investigational Ixazomib in Patients with Newly Diagnosed Multiple Myeloma 2014-12-09 09:30
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS(R) (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting 2014-12-09 09:30
Daiichi Sankyo Launches New Formulation of LIXIANA(R) 60 mg Tablets (edoxaban) in Japan 2014-12-08 21:19
Pyunkang Korean Medicine Hospital: The Great Vision of a Doctor of Korean Medicine Banning Chemical Medicines 2014-12-05 22:00
Takeda's Investigational, Oral Proteasome Inhibitor Ixazomib Granted Breakthrough Therapy Designation by U.S. FDA for Relapsed or Refractory Systemic Light-chain Amyloidosis 2014-12-05 09:30
Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative 2014-12-05 00:53
PneumRx Acquired by BTG plc for up to $475 Million 2014-12-04 15:30
Merck Serono Awards Grant for Growth - Countdown for Accepting Applications 2014-12-04 15:30
China Bolsters International Response to Ebola with USD $6 Million Donation 2014-12-02 18:38
International College of Neuropsychopharmacology (CINP) Calls on Governments to Reverse 'Disturbing' Trend of Lack of New Drugs for the 10% of the Global Population Affected by Brain Diseases 2014-12-01 20:00
1 393 394 395 396 397 401